Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Ancitabine MeSH Descriptor Data 2025


MeSH Heading
Ancitabine
Tree Number(s)
D03.383.742.680.245.453.050
D13.570.065.300.050
D13.570.685.245.453.050
Unique ID
D003504
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D003504
Scope Note
Congener of CYTARABINE that is metabolized to cytarabine and thereby maintains a more constant antineoplastic action.
Entry Term(s)
Anhydro-Ara-C
Cyclo-C
Cyclocytidine
NSC-145,668
NSC-145668
U-33,624A
U-33624A
Pharm Action
Antimetabolites, Antineoplastic
Registry Numbers
DO2D32W0VC
0
Related Numbers
31698-14-3
CAS Type 1 Name
6H-Furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-, (2R-(2alpha,3beta,3abeta,9abeta))-
Previous Indexing
Anhydrides (1974-1975)
Cytarabine (1974-1976)
Cytidine (1973)
Public MeSH Note
96; was CYCLOCYTIDINE 1977-95 (see under CYTARABINE 1977-90)
History Note
96; was CYCLOCYTIDINE 1977-95 (see under CYTARABINE 1977-90)
Date Established
1991/01/01
Date of Entry
1976/04/13
Revision Date
2016/05/27
Ancitabine Preferred
Cyclo-C Narrower
U-33,624A Narrower
NSC-145,668 Narrower
page delivered in 0.147s